Alpine Woods Capital Investors LLC held its stake in shares of HCP, Inc. (NYSE:HCP) during the second quarter, according to its most recent filing with the SEC. The fund owned 16,887 shares of the real estate investment trust’s stock at the end of the second quarter. Alpine Woods Capital Investors LLC’s holdings in HCP were worth $540,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the stock. Peoples Financial Services CORP. raised its stake in shares of HCP by 4.0% in the second quarter. Peoples Financial Services CORP. now owns 3,250 shares of the real estate investment trust’s stock worth $104,000 after buying an additional 125 shares during the period. Founders Capital Management bought a new stake in shares of HCP during the first quarter worth about $106,000. Chicago Partners Investment Group LLC raised its stake in shares of HCP by 252.5% in the second quarter. Chicago Partners Investment Group LLC now owns 3,525 shares of the real estate investment trust’s stock worth $113,000 after buying an additional 2,525 shares during the period. Advisory Services Network LLC bought a new stake in shares of HCP during the first quarter worth about $114,000. Finally, ClariVest Asset Management LLC bought a new stake in shares of HCP during the second quarter worth about $172,000. Institutional investors and hedge funds own 88.87% of the company’s stock.

Shares of HCP, Inc. (HCP) opened at 29.20 on Friday. HCP, Inc. has a 1-year low of $27.61 and a 1-year high of $40.43. The stock’s 50 day moving average price is $30.92 and its 200 day moving average price is $31.24. The company has a market cap of $13.69 billion, a P/E ratio of 19.90 and a beta of 0.37.

HCP (NYSE:HCP) last released its earnings results on Tuesday, August 1st. The real estate investment trust reported $0.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.01. The business had revenue of $458.90 million for the quarter, compared to the consensus estimate of $456.29 million. HCP had a return on equity of 9.96% and a net margin of 32.16%. HCP’s quarterly revenue was down 14.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.71 earnings per share. Equities research analysts forecast that HCP, Inc. will post $1.36 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, August 22nd. Investors of record on Monday, August 7th will be given a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a dividend yield of 5.07%. The ex-dividend date is Thursday, August 3rd. HCP’s dividend payout ratio is currently 102.07%.

TRADEMARK VIOLATION NOTICE: “Alpine Woods Capital Investors LLC Has $540,000 Position in HCP, Inc. (HCP)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/18/alpine-woods-capital-investors-llc-has-540000-position-in-hcp-inc-hcp.html.

A number of equities research analysts have recently issued reports on HCP shares. Mitsubishi UFJ Financial Group started coverage on HCP in a research report on Friday, April 21st. They set a “hold” rating and a $32.00 target price on the stock. Evercore ISI lowered HCP from an “in-line” rating to an “underperform” rating in a research report on Monday, April 24th. Jefferies Group LLC reaffirmed a “hold” rating and set a $32.00 target price on shares of HCP in a research report on Friday, May 12th. UBS AG raised HCP from an “underperform” rating to an “outperform” rating in a research report on Wednesday, June 14th. Finally, Raymond James Financial, Inc. raised HCP from an “underperform” rating to an “outperform” rating and set a $35.00 target price on the stock in a research report on Wednesday, June 14th. Three investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and three have assigned a buy rating to the company’s stock. HCP has an average rating of “Hold” and a consensus target price of $33.42.

In related news, insider Thomas Klaritch sold 2,651 shares of HCP stock in a transaction dated Tuesday, June 13th. The stock was sold at an average price of $31.53, for a total value of $83,586.03. Following the sale, the insider now owns 176,830 shares of the company’s stock, valued at $5,575,449.90. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.22% of the stock is currently owned by insiders.

About HCP

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Stock Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related stocks with our FREE daily email newsletter.